ACET
Price
$0.61
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
50.2M
31 days until earnings call
INBX
Price
$16.33
Change
+$0.59 (+3.75%)
Updated
Jul 3 closing price
Capitalization
236.39M
44 days until earnings call
Interact to see
Advertisement

ACET vs INBX

Header iconACET vs INBX Comparison
Open Charts ACET vs INBXBanner chart's image
Adicet Bio
Price$0.61
Change-$0.00 (-0.00%)
Volume$545.98K
Capitalization50.2M
Inhibrx Biosciences
Price$16.33
Change+$0.59 (+3.75%)
Volume$53.38K
Capitalization236.39M
ACET vs INBX Comparison Chart in %
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. INBX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Hold and INBX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (ACET: $0.61 vs. INBX: $16.33)
Brand notoriety: ACET and INBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACET: 99% vs. INBX: 59%
Market capitalization -- ACET: $50.2M vs. INBX: $236.39M
ACET [@Biotechnology] is valued at $50.2M. INBX’s [@Biotechnology] market capitalization is $236.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 2 FA rating(s) are green whileINBX’s FA Score has 2 green FA rating(s).

  • ACET’s FA Score: 2 green, 3 red.
  • INBX’s FA Score: 2 green, 3 red.
According to our system of comparison, INBX is a better buy in the long-term than ACET.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 4 TA indicator(s) are bullish while INBX’s TA Score has 5 bullish TA indicator(s).

  • ACET’s TA Score: 4 bullish, 5 bearish.
  • INBX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, INBX is a better buy in the short-term than ACET.

Price Growth

ACET (@Biotechnology) experienced а -9.48% price change this week, while INBX (@Biotechnology) price change was +10.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ACET is expected to report earnings on Aug 06, 2025.

INBX is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INBX($236M) has a higher market cap than ACET($50.2M). INBX YTD gains are higher at: 6.039 vs. ACET (-36.902). INBX has higher annual earnings (EBITDA): 1.73B vs. ACET (-110.82M). INBX has more cash in the bank: 217M vs. ACET (150M). ACET has less debt than INBX: ACET (16.2M) vs INBX (107M). INBX has higher revenues than ACET: INBX (200K) vs ACET (0).
ACETINBXACET / INBX
Capitalization50.2M236M21%
EBITDA-110.82M1.73B-6%
Gain YTD-36.9026.039-611%
P/E RatioN/A0.14-
Revenue0200K-
Total Cash150M217M69%
Total Debt16.2M107M15%
FUNDAMENTALS RATINGS
ACET: Fundamental Ratings
ACET
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
21
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACETINBX
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
85%
Momentum
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
67%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BTBT2.940.31
+11.79%
Bit Digital
SKUFF21.53N/A
N/A
Svenska Kullagerfabriken AB
MOYFF1.28N/A
N/A
Mynaric AG
SEGSF2.68N/A
N/A
SIA Engineering Company Ltd.
HOVR1.58-0.06
-3.66%
New Horizon Aircraft Ltd

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with RGNX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
-1.14%
RGNX - ACET
41%
Loosely correlated
+1.39%
SYRE - ACET
41%
Loosely correlated
+1.68%
INBX - ACET
39%
Loosely correlated
+3.75%
ARWR - ACET
39%
Loosely correlated
-0.65%
IPSC - ACET
37%
Loosely correlated
+0.02%
More

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with GBIO. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
+3.75%
GBIO - INBX
40%
Loosely correlated
+1.51%
SCPH - INBX
40%
Loosely correlated
-1.73%
ARCT - INBX
39%
Loosely correlated
+1.17%
IMNM - INBX
38%
Loosely correlated
+2.43%
ACET - INBX
38%
Loosely correlated
-1.14%
More